Nanocarrier Vaccines for SARS-CoV-2.
2021
The SARS-CoV-2 global pandemic has seen rapid spread, disease mobidities and death associated with substantive social, economic and societal impact. Treatments rely on re-purposed antivirals and immune modulatory agents focusing on attenuating the acute respiratory distress syndrome. No curative therapies exist. Vaccines remain the best hope for disease control and elimination and the principal global effort with success now being realized. Herein, we summarize those developments with a focus on the role played by nanocarrier delivery.
Keywords:
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
316
References
26
Citations
NaN
KQI